Lung Imaging Laboratory, Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Global Health and Emerging Pathogens Institute, Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Front Immunol. 2024 Jan 26;15:1328453. doi: 10.3389/fimmu.2024.1328453. eCollection 2024.
Lung infection by influenza A virus (IAV) is a major cause of global mortality from lung injury, a disease defined by widespread dysfunction of the lung's air-blood barrier. Endocytosis of IAV virions by the alveolar epithelium - the cells that determine barrier function - is central to barrier loss mechanisms. Here, we address the current understanding of the mechanistic steps that lead to endocytosis in the alveolar epithelium, with an eye to how the unique structure of lung alveoli shapes endocytic mechanisms. We highlight where future studies of alveolar interactions with IAV virions may lead to new therapeutic approaches for IAV-induced lung injury.
甲型流感病毒(IAV)引起的肺部感染是导致全球因肺部损伤而死亡的主要原因,这种疾病的特征是肺部的气血屏障广泛功能障碍。肺泡上皮细胞(决定屏障功能的细胞)对 IAV 病毒粒子的内吞作用是导致屏障丧失机制的核心。在这里,我们着眼于肺肺泡的独特结构如何影响内吞作用机制,探讨了导致肺泡上皮细胞内吞作用的机制步骤的当前理解。我们强调了未来研究肺泡与 IAV 病毒粒子的相互作用可能为 IAV 诱导的肺部损伤带来新的治疗方法。